AGÕæÈ˹ٷ½

STOCK TITAN

[144] Hims & Hers Health, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Franklin Financial Services Corporation (FRAF) filed a Form 4 disclosing that director Daniel J. Fisher acquired 313 common shares on 06/23/2025 at an implied price of $34.60 per share, totaling roughly $10.8 thousand. The shares were issued in lieu of cash compensation for a portion of Fisher’s board fees. Following the transaction, Fisher directly owns 29,276 shares, a figure that includes previously reported unvested restricted stock units. No derivative securities were involved.

The filing represents a routine compensation-related share issuance rather than an open-market purchase, but it still modestly increases insider equity alignment without altering control dynamics or signaling material changes to FRAF’s capital structure.

Franklin Financial Services Corporation (FRAF) ha presentato un Modulo 4 comunicando che il direttore Daniel J. Fisher ha acquisito 313 azioni ordinarie il 23/06/2025 a un prezzo implicito di 34,60 $ per azione, per un valore totale di circa 10,8 mila $. Le azioni sono state emesse in sostituzione della compensazione in contanti per una parte delle sue retribuzioni da membro del consiglio. Dopo la transazione, Fisher possiede direttamente 29.276 azioni, un numero che include unità azionarie vincolate non ancora maturate precedentemente segnalate. Non sono stati coinvolti strumenti derivati.

La comunicazione rappresenta un’emissione di azioni legata alla compensazione di routine piuttosto che un acquisto sul mercato aperto, ma aumenta comunque modestamente l’allineamento patrimoniale degli insider senza modificare le dinamiche di controllo o indicare cambiamenti significativi nella struttura del capitale di FRAF.

Franklin Financial Services Corporation (FRAF) presentó un Formulario 4 revelando que el director Daniel J. Fisher ²¹»å±ç³Ü¾±°ù¾±Ã³ 313 acciones comunes el 23/06/2025 a un precio implícito de $34.60 por acción, por un total aproximado de $10.8 mil. Las acciones fueron emitidas en lugar de compensación en efectivo por una parte de las tarifas de Fisher como miembro del consejo. Tras la transacción, Fisher posee directamente 29,276 acciones, cifra que incluye unidades de acciones restringidas no adquiridas previamente reportadas. No se involucraron valores derivados.

La presentación representa una emisión rutinaria de acciones relacionada con la compensación, en lugar de una compra en el mercado abierto, pero aún así incrementa modestamente la alineación patrimonial de los insiders sin alterar las dinámicas de control ni señalar cambios materiales en la estructura de capital de FRAF.

Franklin Financial Services Corporation(FRAF)ëŠ� Daniel J. Fisher ì´ì‚¬ê°€ 2025ë…� 6ì›� 23ì¼ì— 313ì£�ì� 보통주를 주당 $34.60ì� 암시 가격으ë¡� ì•� $10,800ì—� ì·¨ë“했다ê³� Form 4ë¥� 통해 공시했습니다. ì� 주ì‹ì€ Fisher ì´ì‚¬ì� ì´ì‚¬íš� 수수ë£� ì¼ë¶€ì—� 대í•� 현금 ë³´ìƒ ëŒ€ì‹� 발행ë� 것입니다. ì´ë²ˆ 거래 í›� Fisher ì´ì‚¬ëŠ� ì´ì „ì—� ë³´ê³ ë� 미확ì � 제한 ì£¼ì‹ ë‹¨ìœ„ë¥� í¬í•¨í•˜ì—¬ ì§ì ‘ 29,276ì£�ë¥� 보유하게 ë˜ì—ˆìŠµë‹ˆë‹�. íŒŒìƒ ì¦ê¶Œì€ í¬í•¨ë˜ì§€ 않았습니ë‹�.

ì´ë²ˆ 공시ëŠ� 공개 시장ì—서ì� 매수가 아닌 ë³´ìƒ ê´€ë � ì£¼ì‹ ë°œí–‰ì� ì¼í™˜ìœ¼ë¡œ, ë‚´ë¶€ìž� ì§€ë¶� ì •ë ¬ì� 다소 ì¦ê°€ì‹œí‚¤ì§€ë§� FRAFì� 지배구ì¡� 변화나 ìžë³¸ 구조ì—� 중대í•� 변화를 시사하지ëŠ� 않습니다.

Franklin Financial Services Corporation (FRAF) a déposé un formulaire 4 révélant que le directeur Daniel J. Fisher a acquis 313 actions ordinaires le 23/06/2025 à un prix implicite de 34,60 $ par action, pour un total d'environ 10,8 milliers de dollars. Les actions ont été émises en lieu et place d'une rémunération en espèces pour une partie des honoraires de Fisher au conseil d'administration. Après la transaction, Fisher détient directement 29 276 actions, un chiffre qui inclut des unités d'actions restreintes non encore acquises précédemment signalées. Aucun titre dérivé n'a été impliqué.

Le dépôt représente une émission d'actions liée à une rémunération de routine plutôt qu'un achat sur le marché ouvert, mais il augmente néanmoins modestement l'alignement des intérêts des initiés sans modifier les dynamiques de contrôle ni signaler de changements significatifs dans la structure du capital de FRAF.

Die Franklin Financial Services Corporation (FRAF) reichte ein Formular 4 ein, das offenlegt, dass Direktor Daniel J. Fisher am 23.06.2025 313 Stammaktien zu einem impliziten Preis von 34,60 $ pro Aktie erworben hat, insgesamt etwa 10,8 Tausend $. Die Aktien wurden anstelle von Barvergütung für einen Teil von Fishers Aufsichtsratsvergütung ausgegeben. Nach der Transaktion besitzt Fisher direkt 29.276 Aktien, eine Zahl, die zuvor gemeldete nicht ausgeübte Restricted Stock Units einschließt. Es waren keine Derivate beteiligt.

Die Meldung stellt eine routinemäßige aktienbezogene Vergütungsausgabe dar und keinen Kauf am offenen Markt, erhöht jedoch dennoch leicht die Eigenkapitalausrichtung der Insider, ohne die Kontrollverhältnisse zu verändern oder wesentliche Änderungen an der Kapitalstruktur von FRAF anzudeuten.

Positive
  • Director increases direct share ownership, modestly aligning board interests with shareholders.
  • Equity-for-fees structure conserves issuer cash while maintaining compensation value.
Negative
  • Transaction size is immaterial (~$10.8k) and unlikely to influence market perception.
  • Not an open-market purchase; therefore, provides limited incremental confidence signal compared with voluntary buys.

Insights

TL;DR: Minor director stock-for-fees grant; immaterial to valuation, marginally positive for alignment.

The acquisition is worth about $10.8k—trivial against FRAF’s market capitalization. Because the shares replace cash, there is no incremental cash outlay by the insider, limiting the usual bullish signal from direct open-market buys. Nonetheless, the grant raises Fisher’s stake to 29,276 shares, strengthening board-shareholder alignment at negligible dilution. From a valuation or earnings standpoint, the event is not impactful; investors may view it as neutral-to-slightly positive sentiment.

TL;DR: Routine equity compensation improves alignment; governance stance unchanged.

Paying a portion of director fees in stock is a common governance practice that encourages long-term oversight focus. The absence of derivative activity and the direct holding form reduce complexity and potential conflict. Because the share count is de minimis relative to outstanding shares, voting power shift is immaterial. Overall effect on governance quality is positive but not materially impactful to shareholders.

Franklin Financial Services Corporation (FRAF) ha presentato un Modulo 4 comunicando che il direttore Daniel J. Fisher ha acquisito 313 azioni ordinarie il 23/06/2025 a un prezzo implicito di 34,60 $ per azione, per un valore totale di circa 10,8 mila $. Le azioni sono state emesse in sostituzione della compensazione in contanti per una parte delle sue retribuzioni da membro del consiglio. Dopo la transazione, Fisher possiede direttamente 29.276 azioni, un numero che include unità azionarie vincolate non ancora maturate precedentemente segnalate. Non sono stati coinvolti strumenti derivati.

La comunicazione rappresenta un’emissione di azioni legata alla compensazione di routine piuttosto che un acquisto sul mercato aperto, ma aumenta comunque modestamente l’allineamento patrimoniale degli insider senza modificare le dinamiche di controllo o indicare cambiamenti significativi nella struttura del capitale di FRAF.

Franklin Financial Services Corporation (FRAF) presentó un Formulario 4 revelando que el director Daniel J. Fisher ²¹»å±ç³Ü¾±°ù¾±Ã³ 313 acciones comunes el 23/06/2025 a un precio implícito de $34.60 por acción, por un total aproximado de $10.8 mil. Las acciones fueron emitidas en lugar de compensación en efectivo por una parte de las tarifas de Fisher como miembro del consejo. Tras la transacción, Fisher posee directamente 29,276 acciones, cifra que incluye unidades de acciones restringidas no adquiridas previamente reportadas. No se involucraron valores derivados.

La presentación representa una emisión rutinaria de acciones relacionada con la compensación, en lugar de una compra en el mercado abierto, pero aún así incrementa modestamente la alineación patrimonial de los insiders sin alterar las dinámicas de control ni señalar cambios materiales en la estructura de capital de FRAF.

Franklin Financial Services Corporation(FRAF)ëŠ� Daniel J. Fisher ì´ì‚¬ê°€ 2025ë…� 6ì›� 23ì¼ì— 313ì£�ì� 보통주를 주당 $34.60ì� 암시 가격으ë¡� ì•� $10,800ì—� ì·¨ë“했다ê³� Form 4ë¥� 통해 공시했습니다. ì� 주ì‹ì€ Fisher ì´ì‚¬ì� ì´ì‚¬íš� 수수ë£� ì¼ë¶€ì—� 대í•� 현금 ë³´ìƒ ëŒ€ì‹� 발행ë� 것입니다. ì´ë²ˆ 거래 í›� Fisher ì´ì‚¬ëŠ� ì´ì „ì—� ë³´ê³ ë� 미확ì � 제한 ì£¼ì‹ ë‹¨ìœ„ë¥� í¬í•¨í•˜ì—¬ ì§ì ‘ 29,276ì£�ë¥� 보유하게 ë˜ì—ˆìŠµë‹ˆë‹�. íŒŒìƒ ì¦ê¶Œì€ í¬í•¨ë˜ì§€ 않았습니ë‹�.

ì´ë²ˆ 공시ëŠ� 공개 시장ì—서ì� 매수가 아닌 ë³´ìƒ ê´€ë � ì£¼ì‹ ë°œí–‰ì� ì¼í™˜ìœ¼ë¡œ, ë‚´ë¶€ìž� ì§€ë¶� ì •ë ¬ì� 다소 ì¦ê°€ì‹œí‚¤ì§€ë§� FRAFì� 지배구ì¡� 변화나 ìžë³¸ 구조ì—� 중대í•� 변화를 시사하지ëŠ� 않습니다.

Franklin Financial Services Corporation (FRAF) a déposé un formulaire 4 révélant que le directeur Daniel J. Fisher a acquis 313 actions ordinaires le 23/06/2025 à un prix implicite de 34,60 $ par action, pour un total d'environ 10,8 milliers de dollars. Les actions ont été émises en lieu et place d'une rémunération en espèces pour une partie des honoraires de Fisher au conseil d'administration. Après la transaction, Fisher détient directement 29 276 actions, un chiffre qui inclut des unités d'actions restreintes non encore acquises précédemment signalées. Aucun titre dérivé n'a été impliqué.

Le dépôt représente une émission d'actions liée à une rémunération de routine plutôt qu'un achat sur le marché ouvert, mais il augmente néanmoins modestement l'alignement des intérêts des initiés sans modifier les dynamiques de contrôle ni signaler de changements significatifs dans la structure du capital de FRAF.

Die Franklin Financial Services Corporation (FRAF) reichte ein Formular 4 ein, das offenlegt, dass Direktor Daniel J. Fisher am 23.06.2025 313 Stammaktien zu einem impliziten Preis von 34,60 $ pro Aktie erworben hat, insgesamt etwa 10,8 Tausend $. Die Aktien wurden anstelle von Barvergütung für einen Teil von Fishers Aufsichtsratsvergütung ausgegeben. Nach der Transaktion besitzt Fisher direkt 29.276 Aktien, eine Zahl, die zuvor gemeldete nicht ausgeübte Restricted Stock Units einschließt. Es waren keine Derivate beteiligt.

Die Meldung stellt eine routinemäßige aktienbezogene Vergütungsausgabe dar und keinen Kauf am offenen Markt, erhöht jedoch dennoch leicht die Eigenkapitalausrichtung der Insider, ohne die Kontrollverhältnisse zu verändern oder wesentliche Änderungen an der Kapitalstruktur von FRAF anzudeuten.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many FRAF shares did director Daniel J. Fisher acquire?

He received 313 common shares on 06/23/2025.

What was the implied price for the shares acquired by the FRAF director?

The shares were valued at approximately $34.60 each.

What is Daniel J. Fisher’s total FRAF shareholding after the transaction?

Following the grant, he directly owns 29,276 shares, including unvested RSUs.

Why were the shares issued to the FRAF director?

They were issued in lieu of cash for a portion of the director’s fees.

Were any derivative securities involved in this Form 4 filing for FRAF?

No, no derivative securities were reported.
Hims & Hers Health Inc

NYSE:HIMS

HIMS Rankings

HIMS Latest News

HIMS Latest SEC Filings

HIMS Stock Data

10.62B
190.62M
11.25%
79.06%
23.34%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
United States
SAN FRANCISCO